Russian scientists from the North-Eastern Federal University and the Krasnoyarsk State Medical University found that Memantine is a drug for the treatment of Alzheimer’s disease – can be effective in the fight against the spinacerebellar attack of 1 type (SCSA1), a deadly hazardous neurodegenerative disease in which The cerebellum is affected. This is reported in a press release on the SDUNUKI website.rf.
Researchers used a mouse model that imitates the SCA1 in people: rodents also occurred neurodegeneration of the cerebellum, and the nerve cells lost the opportunity to function normally. As shown by the results of experiments, memantine has improved the functioning of nerve cells. According to scientists, the use of the drug can stabilize the state of a person, extending life in patients with SCA1. However, people’s tests will begin only after the successful completion of preclinical research.
Research on people will go about two years, while specialists will track the course of the disease and assess the neurological state of the patient. If the drug really slows down the progression of the disease, then scientists will try to determine the long-term effect. When identifying the significant effect of memanthin during the SCA1, it will be possible to expand the readings for the use of this drug.